STOCK TITAN

The Carlyle Group Inc. Stock Price, News & Analysis

CG Nasdaq

Welcome to our dedicated page for The Carlyle Group news (Ticker: CG), a resource for investors and traders seeking the latest updates and insights on The Carlyle Group stock.

The Carlyle Group Inc. (NASDAQ: CG) is a global investment firm in the portfolio management industry, active across Global Private Equity, Global Credit, and Carlyle AlpInvest. News related to Carlyle often reflects its role as a sponsor, backer, or majority owner of companies in sectors such as media services, energy infrastructure, maritime and defense services, specialty insurance, and medical technology.

On this page, readers can follow CG news that includes announcements from Carlyle itself and from businesses in which it holds significant stakes. Recent examples include NEP Group highlighting Carlyle as its largest shareholder in connection with a major equity investment and refinancing, ARMADA Parent Inc. describing itself as majority owned by Carlyle and another private equity firm in an acquisition of Poseidon Industrial, and NineDot Energy noting that it is backed by Carlyle and Manulife in a corporate debt facility to support battery energy storage projects.

Other news items show Carlyle’s presence in specialty insurance and medical device manufacturing through its backing of Vantage Group Holdings and Resonetics. These stories illustrate how Carlyle’s capital supports acquisitions, growth initiatives, and financing transactions across its portfolio.

Investors and observers using this news feed can monitor developments tied to Carlyle’s investment activities, including portfolio company acquisitions, new funding arrangements, and changes in ownership structures where Carlyle is a sponsor or co-sponsor. By reviewing these updates over time, users can gain insight into how Carlyle deploys private capital across its Global Private Equity and Global Credit segments and how those decisions influence companies in multiple industries.

Rhea-AI Summary

On September 21, 2020, The Carlyle Group (NASDAQ: CG) announced a strategic growth investment in TriNetX, acquiring a majority stake in the global health research network. While the transaction details remain undisclosed, TriNetX has established a vast network of 170 healthcare organizations across 30 countries. The investment aims to enhance TriNetX's capabilities in clinical research and accelerate its growth, leveraging AI and analytics. Carlyle's involvement aligns with its long-term healthcare commitment, having invested over $15 billion in the sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.81%
Tags

FAQ

What is the current stock price of The Carlyle Group (CG)?

The current stock price of The Carlyle Group (CG) is $47.29 as of April 10, 2026.

What is the market cap of The Carlyle Group (CG)?

The market cap of The Carlyle Group (CG) is approximately 17.4B.